Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PFKFB4 | Q16877 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.42 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.42 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.42 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2199741 | 0.84 | MEN1 (0.53) | KDM4ECSNK2A2CSNK2BCSNK2A1MEN1 | |
| SCHEMBL31346245 | 0.81 | GPR35 (0.52) | PFKFB4GPR35HCAR2MEN1ALDH1A1 | |
| SCHEMBL13261826 | 0.81 | KMO (0.51) | MEN1KMT2AL3MBTL1SCN9AKMO | |
| SCHEMBL9106265 | 0.73 | KMO (0.45) | MEN1KMT2AL3MBTL1SCN9AKMO | |
| SCHEMBL19072692 | 0.73 | KMO (0.47) | MEN1KMT2AL3MBTL1SCN9AKMO | |
| SCHEMBL863315 | 0.70 | ALPL (0.41) | KDM4EMEN1ALDH1A1KMT2AL3MBTL1 | |
| SCHEMBL2201113 | 0.70 | GP6 (0.59) | KDM4EMEN1ALDH1A1KMT2AL3MBTL1 | |
| SCHEMBL15888380 | 0.70 | CCR1 (0.52) | KDM4EALDH1A1L3MBTL1SCN9ALMNA | |
| SCHEMBL3923995 | 0.70 | KMO (0.45) | ALDH1A1L3MBTL1SCN9AKMO | |
| SCHEMBL9277799 | 0.70 | KDM4E (0.58) | KDM4EMEN1ALDH1A1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2385052-B1 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO LTD (JP) | 2013-11-13 | — | — | EP | disclosed |
| EP-2385052-A1 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | Hodogaya Chemical Co., Ltd. (JP) | 2011-11-09 | — | — | EP | disclosed |
| US-7977671-B2 | Compound having oxadiazole ring structure substituted with pyridyl group and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7812341-B2 | Compound having oxadiazole ring structure substituted with pyridyl group, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100066244-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20080017846-A1 | Compound Having Oxadiazole Ring Structure Substituted with Pyridyl Group, and Organic Electroluminescent Device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2008-01-24 | — | — | US | disclosed |
| EP-1746094-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP, AND ORGANIC ELECTROLUMINESCENT DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2007-01-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100066244-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENCE DEVICE | OXA1L, LEF1, PNPO | PFKFB4 3065/4885KDM4E 608/4885GPR35 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.